🇺🇸 FDA
Pipeline program

CSL Limited Influenza Vaccine

CSLCT-USF-06-28

Approved mab completed

Quick answer

CSL Limited Influenza Vaccine for Influenza is a Approved program (mab) at Seqirus (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Seqirus (Australia) Pty Ltd
Indication
Influenza
Phase
Approved
Modality
mab
Status
completed

Clinical trials